Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
722
Total Claims
$1.5M
Drug Cost
108
Beneficiaries
$14K
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+734%
Opioid rate vs peers
52.4% vs 6.3% avg
+3%
Cost per patient vs peers
$14K vs $14K avg
+39%
Brand preference vs peers
20.4% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 734% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
52.4%
Opioid Rate
378
Opioid Claims
$60K
Opioid Cost
17.7%
Long-Acting Rate
This provider's opioid prescribing rate of 52.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 147 claims · $1.5M
Generic: 575 claims · $25K
Patient Profile
69
Avg Age
44%
Female
2.95
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About